BioNanomatrix develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The Company's technology provides analysis of genomic, epigenomic, and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine, and biomedical research applications.